Skip to main content
Have a personal or library account? Click to login
Studying the formation of aggregates in recombinant human granulocyte-colony stimulating factor (rHuG-CSF), lenograstim, using size-exclusion chromatography and SDS-PAGE Cover

Studying the formation of aggregates in recombinant human granulocyte-colony stimulating factor (rHuG-CSF), lenograstim, using size-exclusion chromatography and SDS-PAGE

Acta Pharmaceutica
Volume 58 (2008): Issue 2 (June 2008)
By: ,  ,   and    
Open Access
|May 2008
References

References

  1. A. K. Pavlou and J. M. Reichert, Recombinant protein therapeutics - success rates, market trends and values to 2010,22 (2004) 1513-1519; DOI: 10.1038/nbt1204-1513.
    Open DOISearch in Google Scholar
  2. A. C. Herman, T. C. Boone and S. Lu,, in(Eds. R. Pearlman and Y. J. Wang), Plenum Press, New York 1996, pp. 303-328.
    Open DOISearch in Google Scholar
  3. V. Gervais, A. Zerial and H. Oschkinat, NMR investigations of the role of the sugar moiety in glycosylated recombinant human G-CSF,247 (1997) 386-395.
    Open DOISearch in Google Scholar
  4. C. Wang, M. Eufemi, C. Turano and A. Giartosio, Influence of the carbohydrate moiety on the stability of glycoproteins,35 (1996) 7299-7307; DOI: 10.1021/bi9517704.
    Open DOISearch in Google Scholar
  5. C. Nissen, Glycosylation of recombinant human granulocyte-colony stimulating factor: implications for stability and potency,30A (Suppl. 3) (1994) S12-S14.
    Search in Google Scholar
  6. M. Oheda, M. Hasegawa, K. Hattori, H. Kuboniwa, T. Kojima, T. Orita, K. Tomonou, T. Yamazaki and N. Ochi, O-linked sugar chain of hG-CSF protects it against polymerization and denaturation allowing it to retain its biological activity,265 (1990) 11432-11436.
    Open DOISearch in Google Scholar
  7. A. Hüttmann, K. Schirsafi, S. Seeber and P. Bojko, Comparison of lenograstim and filgrastim: effects on blood cell recovery after high-dose chemotherapy and autologous peripheral blood stem cell transplantation,131 (2005) 152-156; DOI: 10.1007/s00432-004-0636-x.
    Open DOISearch in Google Scholar
  8. M. Hoglund, B. Smedmyr, M. Bengtsson, T. H. Totterman, U. Cour-Chabernaud and A. Yver, Mobilisation of CD34+ cells by glycosylated and non-glycosylated GSCF in healthy volunteers - A comparative study,59 (1997) 177-183.
    Open DOISearch in Google Scholar
  9. W. Wang, Instability, stabilization, and formulation of liquid protein pharmaceuticals,185 (1999) 129-188; DOI: 10.1016/S0378-5173(99)00152-0.
    Open DOISearch in Google Scholar
  10. E. Y. Chi, S. Krishnan, B. S. Kendrick, B. S. Chang, J. F. Carpenter and T. W. Randolph, Roles of conformational stability and colloidal stability in the aggregation of rHuG-CSF,12 (2003) 903-913.
    Open DOISearch in Google Scholar
  11. S. Krishnan, E. Y. Chi, J. N. Webb, B. S. Chang, D. Shan, M. Goldenberg, M. C. Manning, T. W. Randolph and J. F. Carpenter, Aggregation of G-CSF under physiological conditions: Characterization and thermodynamic inhibition,41 (2002) 6422-6431; DOI: 10.1021/bi 012006m.
    Search in Google Scholar
  12. M. W. Bruner, J. Goldstein, C. R. Middaugh, M. A. Brooks and D. B. Volkin, Size exclusion HPLC method for the determination of acidic fibroblast growth factor in viscous formulations,15 (1997) 1929-1935; DOI: 10.1016/S0731-7085(96)02043-2.
    Open DOISearch in Google Scholar
  13. K. Ahrer, A. Buchacher, G. Iberer and A. Jungbauer, Detection of aggregate formation during production of human immunoglobulin G by means of light scattering,1043 (2004) 41-46; DOI: 10.1016/j.chroma.2004.05.024.
    Open DOISearch in Google Scholar
  14. R. S. Gunturi, I. Ghobrial and B. Sharma, Development of a sensitive size exclusion HPLC method with fluorescence detection for the quantitation of rHuEPO aggregates,43 (2007) 213-221; DOI: 10.1016/j.jpba.2006.06.006.
    Open DOISearch in Google Scholar
  15. J. P. Gabrielson, M. L. Brader, A. H. Pekar, K. B. Mathis, G. Winter, J. F. Carpenter and T. W. Randolph, Quantitation of aggregate levels in a recombinant humanized monoclonal antibody formulation by size-exclusion chromatography, asymmetrical flow field flow fractionation and sedimentation velocity,96 (2007) 268-279; DOI: 10.1002/jps.20760.
    Open DOISearch in Google Scholar
  16. C. F. Codevilla, L. Brum, P. R. de Oliveira, C. Dolman, B. Rafferty and S. L. Dalmora, Validation of an SEC-HPLC method for the analysis of rhG-CSF in pharmaceutical formulation,27 (2004) 2689-2698; DOI: 10.1081/JLC-200029121.
    Open DOISearch in Google Scholar
  17. S. W. Raso, J. Abel, J. M. Barnes, K. M. Maloney, G. Pipes, M. J. Treuheit, J. King and D. N. Brems, Aggregation of granulocyte-colony stimulating factor in vitro involves a conformationally altered monomeric state,14 (2005) 2246-2257; DOI: 10.1110/ps.051489405.
    Open DOISearch in Google Scholar
  18. U. K. Laemmli, Cleavage of structural proteins during the assembly of the head of bacteriophage T4,227 (1970) 680-685; DOI: 10.1038/227680a0.
    Open DOISearch in Google Scholar
  19. M. E. Cromwell, E. Hilario and F. Jacobson, Protein aggregation and bioprocessing,8 (2006) E572-E579; DOI: 10.1208/aapsj080366.
    Open DOISearch in Google Scholar
DOI: https://doi.org/10.2478/v10007-008-0003-6 | Journal eISSN: 1846-9558 | Journal ISSN: 1330-0075
Journal RSS Feed
Language: English, Croatian
Page range: 199 - 206
Published on: May 30, 2008
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Keywords:
lenograstim,
aggregate formation,
size-exclusion high-performance liquid chromatography,
sodium dodecyl sulphate-polyacrylamide gel electrophoresis
Related subjects:
Pharmacy,
Pharmacy, other

© 2008 Jasmina Ribarska, Suzana Jolevska, Ana Panovska, Aneta Dimitrovska, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons License.

Volume 58 (2008): Issue 2 (June 2008)
Previous article
Next article